Quantification of unbound concentration of ticagrelor in plasma as a proof of mechanism biomarker of the reversal agent, MEDI2452

• Ann-Sofie Sandinge ,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: ann-sofie.sandinge@astrazeneca.com

  Affiliation Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden

  http://orcid.org/0000-0002-1322-2580

  ⨯
• Annika Janefeldt,

  Roles Conceptualization, Data curation, Methodology, Validation, Writing – original draft, Writing – review & editing

  Affiliation Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden

  ⨯
• Susanne Pehrsson,

  Roles Data curation, Formal analysis, Investigation, Software, Validation, Writing – review & editing

  Affiliation Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden

  ⨯
• Sven Nylander

  Roles Funding acquisition, Resources, Supervision, Writing – review & editing

  Affiliation Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden

  ⨯